Announced
Completed
Financials
Tags
Completed
Venture Capital
Cross Border
Single Bidder
Health Care Services
Private Equity
Acquisition
United Kingdom
Minority
mental health care
Private
Friendly
Synopsis
ATAI Life Sciences, a global biotech company builder, led a $80m Series B round in COMPASS Pathways, a mental health care company. The Series B funding comes from investors, such as Founders Fund, Able Partners, Camden Partners Nexus, Perceptive Advisors, Skyviews Life Science, and Soleus Capital. "We've been with the COMPASS team from the very beginning and share a goal of bringing innovation to those who suffer with mental illness. We believe COMPASS is setting a new standard for innovation in mental health care and we're proud to be playing a part in this," Florian Brand, ATAI Life Sciences CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.